Literature DB >> 7664243

Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer.

R Seruca1, R F Suijkerbuijk, F Gärtner, B Criado, I Veiga, D Olde-Weghuis, L David, S Castedo, M Sobrinho-Simões.   

Abstract

The cytogenetic study of a nodal metastasis from a gastric carcinoma, after two passages in nude mice, revealed a large number of double minutes. Comparative genomic in situ hybridization (CGH) analysis using DNA extracted from this xenograft revealed the existence of three clear amplification units that originated from the chromosomal subregions 6q24-25, 7q31-32, and 8q24 in the xenograft DNA. Similar, though less prominent, CGH results were found with DNAs extracted from the primary tumor and its metastasis, implying that the same amplicons were also present, albeit less abundantly, in the DNAs of these neoplastic tissues. Southern analysis of the second-passage xenograft detected 18- and 10-fold amplification of MET (located at 7q31) and MYC (located at 8q24), respectively. The retrospective study of the first passage of the xenograft, as well as of the metastatic and primary tumors before xenografting, showed amplification levels of MET of, respectively, 12-, 9-, and 5-fold and MYC of, respectively, 8-, 7-, and 5-fold. Our results suggest that increased levels of co-amplification of MYC and MET correlate with enhanced growth potential in this case of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664243     DOI: 10.1016/0165-4608(95)00033-l

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.

Authors:  Ghasem Janbabai; Ziaeddin Oladi; Touraj Farazmandfar; Tarang Taghvaei; Farshad Naghshvar
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-29       Impact factor: 4.553

Review 2.  Interplay between DNA repair and inflammation, and the link to cancer.

Authors:  Dawit Kidane; Wook Jin Chae; Jennifer Czochor; Kristin A Eckert; Peter M Glazer; Alfred L M Bothwell; Joann B Sweasy
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-13       Impact factor: 8.250

3.  Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.

Authors:  G A Gmyrek; M Walburg; C P Webb; H M Yu; X You; E D Vaughan; G F Vande Woude; B S Knudsen
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  MET expression and amplification in patients with localized gastric cancer.

Authors:  Yelena Y Janjigian; Laura H Tang; Daniel G Coit; David P Kelsen; Todd D Francone; Martin R Weiser; Suresh C Jhanwar; Manish A Shah
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-10       Impact factor: 4.254

Review 5.  Tools used to assay genomic instability in cancers and cancer meiomitosis.

Authors:  Jennifer Gantchev; Brandon Ramchatesingh; Melissa Berman-Rosa; Daniel Sikorski; Keerthenan Raveendra; Laetitia Amar; Hong Hao Xu; Amelia Martínez Villarreal; Daniel Josue Guerra Ordaz; Ivan V Litvinov
Journal:  J Cell Commun Signal       Date:  2021-11-29       Impact factor: 5.908

6.  Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.

Authors:  Hua Liu; Changlin Qian; Zhiyong Shen
Journal:  Tumour Biol       Date:  2014-06-12

Review 7.  MET pathway as a therapeutic target.

Authors:  Eric S Kim; Ravi Salgia
Journal:  J Thorac Oncol       Date:  2009-04       Impact factor: 15.609

8.  Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data.

Authors:  Michael Baudis
Journal:  BMC Cancer       Date:  2007-12-18       Impact factor: 4.430

9.  MET amplification as a potential therapeutic target in gastric cancer.

Authors:  Hisato Kawakami; Isamu Okamoto; Tokuzo Arao; Wataru Okamoto; Kazuko Matsumoto; Hirokazu Taniguchi; Kiyoko Kuwata; Haruka Yamaguchi; Kazuto Nishio; Kazuhiko Nakagawa; Yasuhide Yamada
Journal:  Oncotarget       Date:  2013-01

10.  Genomic profile analysis of diffuse-type gastric cancers.

Authors:  Yeon-Su Lee; Yun Sung Cho; Geon Kook Lee; Sunghoon Lee; Young-Woo Kim; Sungwoong Jho; Hak-Min Kim; Seung-Hyun Hong; Jung-Ah Hwang; Sook-young Kim; Dongwan Hong; Il Ju Choi; Byung Chul Kim; Byoung-Chul Kim; Chul Hong Kim; Hansol Choi; Youngju Kim; Kyung Wook Kim; Gu Kong; Hyung Lae Kim; Jong Bhak; Seung Hoon Lee; Jin Soo Lee
Journal:  Genome Biol       Date:  2014-04-01       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.